Novel inhibitors of PSMB7 and PSMB10 for the treatment of multiple myeloma
Ended Project Grant Awarded Last action
- Award ID
- R41CA221494
- Recipient
-
Inhiprot LLC UEI GSX2BKBLGDM7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $296,354
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Alabama, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $296,354 |
Quick answers
Who received award R41CA221494?
R41CA221494 was awarded to Inhiprot LLC by National Cancer Institute (National Institutes of Health) on September 25, 2017.
How much is award R41CA221494 worth?
$296,354 has been obligated on R41CA221494.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award